Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials

[1] Thakkar JP(2020)Leptomeningeal metastasis from solid tumors J Neurol Sci 411 116706-57

[2] Kumthekar P(1995)Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis Ann Neurol 38 51-v95

[3] Dixit KS(2021)Advances in the diagnosis, evaluation, and management of leptomeningeal disease Neuro-Oncol Adv 3 v86-35

[4] Freilich RJ(2018)Leptomeningeal metastasis from systemic cancer: review and update on management Cancer 124 21-879

[5] Krol G(2010)Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours Lancet Oncol 11 871-316

[6] Deangelis LM(2022)Intrathecal delivery and its applications in leptomeningeal disease Adv Drug Deliv Rev 186 114338-451

[7] Sener U(2008)Continuous intrathecal treatment with methotrexate via subcutaneous port: implication for leptomeningeal dissemination of malignant tumors J Neuro-Oncol 87 309-368

[8] Kumthekar P(1981)Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma Pediatr Neurosurg 8 444-7

[9] Boire A(2014)Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study J Neuro-Oncol 119 361-1722

[10] Wang N(2018)The comparative treatment of intraventricular chemotherapy by ommaya reservoir vs. lumbar puncture in patients with leptomeningeal carcinomatosis Front Oncol 8 1-84

[1] Thakkar JP(2020)Leptomeningeal metastasis from solid tumors J Neurol Sci 411 116706-57

[2] Kumthekar P(1995)Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis Ann Neurol 38 51-v95

[3] Dixit KS(2021)Advances in the diagnosis, evaluation, and management of leptomeningeal disease Neuro-Oncol Adv 3 v86-35

[4] Freilich RJ(2018)Leptomeningeal metastasis from systemic cancer: review and update on management Cancer 124 21-879

[5] Krol G(2010)Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours Lancet Oncol 11 871-316

[6] Deangelis LM(2022)Intrathecal delivery and its applications in leptomeningeal disease Adv Drug Deliv Rev 186 114338-451

[7] Sener U(2008)Continuous intrathecal treatment with methotrexate via subcutaneous port: implication for leptomeningeal dissemination of malignant tumors J Neuro-Oncol 87 309-368

[8] Kumthekar P(1981)Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma Pediatr Neurosurg 8 444-7

[9] Boire A(2014)Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study J Neuro-Oncol 119 361-1722

[10] Wang N(2018)The comparative treatment of intraventricular chemotherapy by ommaya reservoir vs. lumbar puncture in patients with leptomeningeal carcinomatosis Front Oncol 8 1-84